跳至主要内容
临床试验/DRKS00020911
DRKS00020911已完成1 期

Bioequivalence of Zofenopril and Nebivolol following their oral co-administration as fixed or extemporaneous combination in healthy volunteers. An open label, randomized, two periods, two sequences, cross-over study - ZOF-NEB-01

Menarini Ricerche S.p.A.0 个研究点目标入组 37 人开始时间: 2020年6月30日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
37

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Properly executed written informed consent form (ICF). -
  • Healthy males and females, aged 18 to 60 years, inclusive, at the screening visit. -
  • BMI between 18.5 Kg/m2 and 30 Kg/m2, inclusive, and weighs at least 50 kg at screening. -
  • Extensive metabolizers for CYP2D6. -
  • Systolic blood pressure (SBP) = 90 mmHg and diastolic blood pressure (DBP) = 60 mmHg ; PR = 60 bpm.

排除标准

  • Any condition which might interfere with the absorption, distribution, metabolism or excretion of the drugs. -
  • Subjects receiving concomitant treatment with other investigational drugs or having participated in another clinical trial within the previous 6 months before their inclusion in the study (i.e., ICF signature date). -
  • Poor metabolizers for CYP2D6. -
  • Previous or current COVID-19 disease.

研究者

发起方
Menarini Ricerche S.p.A.

相似试验

已完成
1 期
Bioequivalence (amount of the product absorbed and distributed in the organism, as well as the speed of the processes) of two active products (nebivolol and ramipril) after administration to healthy subjects as fixed (in a single tablet) and extemporaneous (two tablets administered together) combinationPhase I study in healthy volunteers of both sexes
ISRCTN16567742Menarini Group (Italy)54
进行中(未招募)
不适用
Comparison the effects of Nebivolol versus Metoprolol succinate on endothelial function and large artery stiffness.A parallel group, randomized, double-blind, active control phase IV clinical trialNEMENDAS - NEMENDASAtherosclerosis
EUCTR2005-001578-28-EEBerlin-Chemie AG Menarini Group80
招募中
4 期
Bioequivalence Study of 5 mg Nebivolol Tablets in Healthy Thai Volunteers under Fasting ConditionsRecently&#44Company has manufactured a new formulation of nebivolol tablets 5 mg for which this study has been planned to evaluate the pharmacokinetics of the new formulation.
TCTR20161115001Research and Development48
进行中(未招募)
不适用
Comparison between zofenopril and ramipril in combination with ASA on the extent of cardiovascular risk in patients with systolic left ventricular dysfunction after acute myocardial infarction (SMILE IV trial) - MEN/03/ZOF-CHF/001Protocol Final version dated: 23 Dec 2003Amendment No. 1 Final version dated: 01 Jul 2004Amendment No. 2 Final version dated: 26 Apr 2005 - SMILE IVSystolic left ventricular dysfunction after AMIMedDRA version: 7.0Level: LLTClassification code 10049694
EUCTR2004-001150-88-ESMenarini International Operation Luxembourg -SA896
进行中(未招募)
1 期
Comparison between zofenopril and ramipril in combination with ASA on the extent of cardiovascular risk in patients with systolic left ventricular dysfunction after acute myocardial infarction (SMILE IV trial) - MEN/03/ZOF-CHF/001 Protocol Final version dated: 23 Dec 2003 Amendment No. 1 Final version dated: 01 Jul 2004 - SMILE IVSystolic left ventricular dysfunction after AMIMedDRA version: 7.0 Level: LLT Classification code 10049694
EUCTR2004-001150-88-IEMenarini International Operation Luxembourg -SA
Bioequivalence of Zofenopril and Nebivolol following... | 临床试验